CITROSIL SPRAY 100ML 0.175%

CITROSIL CUTANEA/SPRAY CUTANEO, SOLUTION

active ingredients

100 ml of skin solution contain: ACTIVE PRINCIPLE: benzalconio chloride g 0.175. For the full list of excipients, see paragraph 6.1.

Excellent

Lemon essence, thyme essence, ethyl alcohol, polysorbate 20, edetate tetradine, yellow chinoline (E 104), blue patent (E 131), hydrochloric acid, purified water.

Therapeutic indications

Disinfection and cleansing of the skin also soothing (lower, escoriations, abrasions, burns).

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. Do not administer children under the age of 1 year.

Population

Method of administration Solution Ready to use solution. It must be used pure. Cute integrates: fry the affected area with gauze filled with solution. Surface lesions: apply the product with a sterile gauze pack. Apply two – three times a day. Spray Nebulize on the part to treattwo – three times a day. DON'T OVERDO IT.

Conservation

Store in the original packaging to protect the medicine from light and heat. For storage conditions after first opening see paragraph 6.3.6.5

Warnings

The product is only for external use. Avoid contact with eyes, brain, meninges and middle ear. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor. Do not use for mucous membrane disinfection. The use, especially if prolonged, of products for topical use can give rise to phenomena of sensitization; in this case stop treatment and consult your doctor. Ingestion or accidental inhalation of some disinfectants may have serious, sometimes fatal consequences. Avoid exposure to ultraviolet rays (oven or artificial sources) after application of the product.

Interactions

Avoid the contemporary use of other antiseptics and detergents. Pediatric population Interaction studies were carried out only in adults.

Effects

The following adverse reactions were identified after authorization to use chloride benzalconio. Since these reactions come from spontaneous signals, it is not always possible to define the frequency. It is possible, in some cases, the occurrence of intolerance (burning or irritation), however without consequences, which does not require modification of treatment. Pediatric population They are expected in the pediatric population the same frequency, type and severity of the unwanted effects of the adult population. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the Nazi reporting system at: www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose damage has been reported under normal conditions. Accidental ingestion can cause nausea and vomiting. Symptoms of intoxication resulting in ingestion of significant amounts of quaternary ammonia compounds include dispnea, cyanosis, asphyxiation, resulting in paralysis of respiratory muscles, SNC depression, hypotension and coma. In man the lethal dose is ca.1–3g. The treatment of poisoning is symptomatic: administer if necessary of lenitives. Avoid emesis and gastric lavender.

Pregnancy

The product should only be used in cases of actual need. During the breastfeeding period, avoid the application of the product on the breast to avoid the ingestion of the product by the infant.

Source: Farmadati